从爱沙尼亚塔林的污水中分离到的高度变异的 2 型和 3 型疫苗衍生脊髓灰质炎病毒。
Highly divergent type 2 and 3 vaccine-derived polioviruses isolated from sewage in Tallinn, Estonia.
机构信息
National Institute for Health and Welfare (THL), Helsinki, Finland.
出版信息
J Virol. 2013 Dec;87(23):13076-80. doi: 10.1128/JVI.01174-13. Epub 2013 Sep 18.
Abstract
Highly divergent vaccine-derived polioviruses (VDPVs) have been isolated from sewage in Tallinn, Estonia, since 2002. Sequence analysis of VDPVs of serotypes 2 and 3 showed that they shared common noncapsid region recombination sites, indicating origination from a single trivalent oral polio vaccine dose, estimated to have been given between 1986 and 1998. The sewage isolates closely resemble VDPVs chronically excreted by persons with common variable immunodeficiency, but no chronic excretors have yet been identified in Estonia.
摘要
自 2002 年以来，在爱沙尼亚塔林的污水中已经分离到了高度变异的疫苗衍生脊髓灰质炎病毒（VDPV）。对血清型 2 和 3 的 VDPV 的序列分析表明，它们具有共同的非衣壳区重组位点，表明起源于单次使用三价口服脊髓灰质炎疫苗，估计接种时间在 1986 年至 1998 年之间。污水分离株与常见可变免疫缺陷患者慢性排泄的 VDPV 非常相似，但在爱沙尼亚尚未发现慢性排泄者。
相似文献
1
Highly divergent type 2 and 3 vaccine-derived polioviruses isolated from sewage in Tallinn, Estonia.从爱沙尼亚塔林的污水中分离到的高度变异的 2 型和 3 型疫苗衍生脊髓灰质炎病毒。
J Virol. 2013 Dec;87(23):13076-80. doi: 10.1128/JVI.01174-13. Epub 2013 Sep 18.
2
Highly divergent neurovirulent vaccine-derived polioviruses of all three serotypes are recurrently detected in Finnish sewage.在芬兰的污水中，经常检测到三种血清型的高变异神经毒力疫苗衍生脊髓灰质炎病毒。
Euro Surveill. 2010 May 13;15(19):pii/19566.
3
[Analysis on identification and genetic character of type I vaccine-derived poliovirus in Shanxi province in 2007].2007年山西省Ⅰ型疫苗衍生脊髓灰质炎病毒的鉴定及基因特征分析
Zhongguo Yi Miao He Mian Yi. 2009 Apr;15(2):131-4.
4
Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia.从爱沙尼亚污水中分离出的一株高度进化的3型疫苗衍生脊髓灰质炎病毒的特性分析。
J Virol. 2004 May;78(9):4876-83. doi: 10.1128/jvi.78.9.4876-4883.2004.
5
Characterization of a rare natural intertypic type 2/type 3 penta-recombinant vaccine-derived poliovirus isolated from a child with acute flaccid paralysis.从急性弛缓性麻痹患儿中分离到的一株罕见的天然两型/三型重组疫苗衍生脊灰病毒的特性研究。
J Gen Virol. 2010 Feb;91(Pt 2):421-9. doi: 10.1099/vir.0.014258-0. Epub 2009 Oct 21.
6
[Complete Genome Characterization of Vaccine-derived Polioviruses Isolated in Yunnan,China].[中国云南分离的疫苗衍生脊髓灰质炎病毒的全基因组特征分析]
Bing Du Xue Bao. 2016 Jul;32(4):459-64.
7
Retrospective characterization of a vaccine-derived poliovirus type 1 isolate from sewage in Greece.希腊污水中一株1型疫苗衍生脊髓灰质炎病毒分离株的回顾性特征分析
Appl Environ Microbiol. 2007 Nov;73(21):6697-704. doi: 10.1128/AEM.00535-07. Epub 2007 Sep 7.
8
[Genetic Characteristics of Type 2 Vaccine-derived Poliovirus in Shanxi Province (China) in 2014].2014年中国山西省2型疫苗衍生脊髓灰质炎病毒的基因特征
Bing Du Xue Bao. 2015 Mar;31(2):157-63.
9
Neurovirulent vaccine-derived polioviruses in sewage from highly immune populations.高免疫人群粪便中的神经毒力疫苗衍生脊髓灰质炎病毒。
PLoS One. 2006 Dec 20;1(1):e69. doi: 10.1371/journal.pone.0000069.
10
Circulating vaccine-derived polioviruses in the Extreme North region of Cameroon.喀麦隆极北地区的循环疫苗衍生脊髓灰质炎病毒。
J Clin Virol. 2015 Jan;62:80-3. doi: 10.1016/j.jcv.2014.11.027. Epub 2014 Nov 29.
引用本文的文献
1
Case of Poliomyelitis Caused by Significantly Diverged Derivative of the Poliovirus Type 3 Vaccine Sabin Strain Circulating in the Orphanage.脊灰疫苗衍生病毒 3 型疫苗株引起院内流行的明显差异衍生株所致脊髓灰质炎病例
Viruses. 2020 Sep 1;12(9):970. doi: 10.3390/v12090970.
2
Updated modelling of the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus (iVDPV) excreters.免疫缺陷相关长期疫苗衍生脊髓灰质炎病毒（iVDPV）排出者流行率的更新建模。
Epidemiol Infect. 2019 Oct 24;147:e295. doi: 10.1017/S095026881900181X.
3
The detection of 3 ambiguous type 2 vaccine-derived polioviruses (VDPV2s) in Uganda.在乌干达发现了 3 株 2 型疫苗衍生脊髓灰质炎病毒（VDPV2）。
Virol J. 2018 Apr 27;15(1):77. doi: 10.1186/s12985-018-0990-y.
4
Dynamics of Evolution of Poliovirus Neutralizing Antigenic Sites and Other Capsid Functional Domains during a Large and Prolonged Outbreak.脊髓灰质炎病毒中和抗原位点和其他衣壳功能域在一次大规模和长期暴发中的进化动力学。
J Virol. 2018 Apr 13;92(9). doi: 10.1128/JVI.01949-17. Print 2018 May 1.
5
Insights from a Systematic Search for Information on Designs, Costs, and Effectiveness of Poliovirus Environmental Surveillance Systems.脊髓灰质炎病毒环境监测系统的设计、成本及有效性信息的系统检索见解
Food Environ Virol. 2017 Dec;9(4):361-382. doi: 10.1007/s12560-017-9314-4. Epub 2017 Jul 7.
6
Wild and vaccine-derived poliovirus circulation, and implications for polio eradication.野生和疫苗衍生脊髓灰质炎病毒的传播及其对根除脊髓灰质炎的影响。
Epidemiol Infect. 2017 Feb;145(3):413-419. doi: 10.1017/S0950268816002569. Epub 2016 Nov 21.
7
Molecular and Phenotypic Characterization of a Highly Evolved Type 2 Vaccine-Derived Poliovirus Isolated from Seawater in Brazil, 2014.2014年从巴西海水中分离出的一种高度进化的2型疫苗衍生脊髓灰质炎病毒的分子和表型特征
PLoS One. 2016 Mar 28;11(3):e0152251. doi: 10.1371/journal.pone.0152251. eCollection 2016.
8
Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs.免疫缺陷相关的长期疫苗衍生脊髓灰质炎病毒排泄者患病率建模及抗病毒药物的潜在益处
BMC Infect Dis. 2015 Sep 17;15:379. doi: 10.1186/s12879-015-1115-5.
9
Detection of pathogenic viruses in sewage provided early warnings of hepatitis A virus and norovirus outbreaks.污水中致病病毒的检测为甲型肝炎病毒和诺如病毒的爆发提供了早期预警。
Appl Environ Microbiol. 2014 Nov;80(21):6771-81. doi: 10.1128/AEM.01981-14. Epub 2014 Aug 29.
10
Update on vaccine-derived polioviruses - worldwide, July 2012-December 2013.疫苗衍生脊髓灰质炎病毒最新情况-全球，2012 年 7 月-2013 年 12 月。
MMWR Morb Mortal Wkly Rep. 2014 Mar 21;63(11):242-8.
本文引用的文献
1
Progress toward eradication of polio--worldwide, January 2011-March 2013.2011年1月至2013年3月全球消灭脊髓灰质炎的进展情况。
MMWR Morb Mortal Wkly Rep. 2013 May 3;62(17):335-8.
2
Evaluating surveillance indicators supporting the Global Polio Eradication Initiative, 2011-2012.评价支持全球根除脊髓灰质炎倡议的监测指标，2011-2012 年。
MMWR Morb Mortal Wkly Rep. 2013 Apr 12;62(14):270-4.
3
Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria.在尼日利亚北部的一次大规模疫情中，出现了多种独立的 2 型疫苗衍生脊髓灰质炎病毒。
J Virol. 2013 May;87(9):4907-22. doi: 10.1128/JVI.02954-12. Epub 2013 Feb 13.
4
Update on vaccine-derived polioviruses--worldwide, April 2011-June 2012.疫苗衍生脊灰病毒最新情况——全球，2011 年 4 月至 2012 年 6 月。
MMWR Morb Mortal Wkly Rep. 2012 Sep 21;61:741-6.
5
Common and diverse features of cocirculating type 2 and 3 recombinant vaccine-derived polioviruses isolated from patients with poliomyelitis and healthy children.共同且多样的特征：2 型和 3 型重组疫苗衍生脊髓灰质炎病毒，从脊髓灰质炎患者和健康儿童中分离。
J Infect Dis. 2012 May 1;205(9):1363-73. doi: 10.1093/infdis/jis204. Epub 2012 Mar 29.
6
"A rose is a rose is a rose," but CVID is Not CVID common variable immune deficiency (CVID), what do we know in 2011?“玫瑰就是玫瑰就是玫瑰”，但 CVID 并非 CVID——普通变异型免疫缺陷（CVID），在 2011 年我们对它了解多少？
Adv Immunol. 2011;111:47-107. doi: 10.1016/B978-0-12-385991-4.00002-7.
7
Role of environmental poliovirus surveillance in global polio eradication and beyond.环境脊灰病毒监测在全球消灭脊灰行动及其他方面的作用。
Epidemiol Infect. 2012 Jan;140(1):1-13. doi: 10.1017/S095026881000316X. Epub 2011 Aug 18.
8
Update on vaccine-derived polioviruses--worldwide, July 2009-March 2011.疫苗衍生脊灰病毒最新情况—全球，2009 年 7 月至 2011 年 3 月。
MMWR Morb Mortal Wkly Rep. 2011 Jul 1;60(25):846-50.
9
Vaccine-derived poliomyelitis 12 years after infection in Minnesota.明尼苏达州感染后 12 年出现疫苗衍生脊髓灰质炎
N Engl J Med. 2011 Jun 16;364(24):2316-23. doi: 10.1056/NEJMoa1008677.
10
Highly divergent neurovirulent vaccine-derived polioviruses of all three serotypes are recurrently detected in Finnish sewage.在芬兰的污水中，经常检测到三种血清型的高变异神经毒力疫苗衍生脊髓灰质炎病毒。
Euro Surveill. 2010 May 13;15(19):pii/19566.
Zotero 插件